Organisation Summary Business Sector:Criminal Justice & Health Business Activities:Drug and alcohol services: support, advice, counselling, group work, intensive training Business Location:London, Hull Chief Executive:Mike Trace Turnover:£18m+ (2013-14) Employees:489 Legal structure:Charity and Company Limited by Guarantee Website:www.rapt.org.uk RAPt (Rehabilitation for Addicted Prisoners Trust) helps people overcome the grip of addiction, giving them the opportunity to lead positive and fulfilling drug-free and crime-free lives. In 1992 RAPt founded the first drug treatment facility in a UK prison. Today it is the leading provider of intensive, abstinence-based drug and alcohol rehabilitation programmes in UK prisons, and provides high-quality drug and alcohol services to over 20,000 people every year within the criminal justice system and in the community. RAPt delivers treatment and aftercare programmes. These provide a variety of support, including advice, counselling, group work and intensive treatment. RAPt works with the families and carers of substance misusers, as well as substance misusers themselves. RAPt also contributes to learning in the treatment of drug and alcohol issues through research, and to the quality of the sector through its training and volunteering programmes. The interventions of RAPt are proven to make a real difference. A comprehensive study undertaken in 2011 using Police National Computer (PNC) data, verified by the University of Manchester and Western Carolina University, showed that RAPt achieved a 20% reduction in the numbers of released prisoners re-offending (using the Doncaster method of calculation), and a 65% reduction in overall number of offences (using the Peterborough method of calculation). E3M Member Name:Mike Trace Title :Chief Executive Mike has an extensive background of working on and managing projects providing treatment to the homeless, drug users and offenders. From 1997-2001 Mike held the post of Deputy UK Anti-Drug Co-ordinator where he created a national drug strategy. From 2000 to 2003, he was the chair of the the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA). During 2001 to 2002, Mike also held the post of director of performance at the National Treatment Agency, set up by the UK government to oversee the rapid expansion of the drug treatment sector. In 2002, Mike left to work for the United Nations Office on Drugs and Crime in Vienna and in early 2003 returned to the UK, and the non-governmental sector. After a year as chief executive of The Blenheim Project, a provider of community treatment services in London, he took up his current post at RAPt in 2004. Mike continues to engage in policy issues as Co-ordinator of the International Drug Policy Forum, with an interest in the promotion of evidence-based drug policy.